Log in
Start free trial
Book a demo
Product
Media Database
Find the right journalists
Online Newsroom
Shape your own narrative
Press Release Creator
Create and send press releases
Media Monitoring
Track every single online mention
Media Pitching Tool
Contact recommendations & stats
PR Reports
Showcase the impact of your work
PR CRM
Manage contacts in easy way
AI PR Software
Use AI to save time on your workflow
Social Media Listening
Get a full overview of your brand's presence
Pricing
Top journalists
Top outlets
Book a demo
Log in
Start free trial
Media Database
>
Antonio Regalado
Antonio Regalado
Senior Editor, Biomedicine at
MIT Technology Review
Contact this person
Email address
a*****@*******.com
Get email address
Influence score
53
Phone
(XXX) XXX-XXXX
Get mobile number
Location
United States
Languages
Covering topics
Biotechnology
View more media outlets and journalists by signing up to Prowly
View latest data and reach out all from one place
Sign up for free
Recent Articles
technologyreview.com
The short, strange history of gene de-extinction
Researchers are moving DNA information from past species to living ones.
about 1 month ago
technologyreview.com
Adventures in the genetic time machine
Ancient DNA is telling us more and more about humans and environments long past. Could it also help rescue the future?
about 2 months ago
technologyreview.com
Meta has an AI for brain typing, but it’s stuck in the lab
The social network company hopes neuroscience will give it an advantage in the AI race.
2 months ago
technologyreview.com
OpenAI has created an AI model for longevity science
OpenAI is making a foray into scientific discovery with an AI built to help manufacture stem cells.
3 months ago
technologyreview.com
What to expect from Neuralink in 2025
More volunteers will get Elon Musk’s brain implant, but don’t expect a product soon.
3 months ago
technologyreview.com
Stem-cell therapies that work: 10 Breakthrough Technologies 2025
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.
3 months ago
technologyreview.com
Drugs like Ozempic now make up 5% of prescriptions in the US
The ever-increasing use of GLP-1 agonists is uncovering clues about what else they can do.
4 months ago
technologyreview.com
The 8 worst technology failures of 2024
Vertical farms, woke AI, and 23andMe made our annual list of failed tech.
4 months ago
technologyreview.com
Two Nobel Prize winners want to cancel their own CRISPR patents in ...
There’s a surprise twist in the battle to control genome editing.
7 months ago
technologyreview.com
How machine learning is helping us probe the secret names of animals
You can add marmoset monkeys to the list of species that use “names.” But whether animals have anything more to say remains unknown.
8 months ago
technologyreview.com
Beyond gene-edited babies: the possible paths for tinkering with hu...
CRISPR will get easier and easier to administer. What does that mean for the future of our species?
8 months ago